Eurofins Scientific SE Statistics

Total Valuation

Eurofins Scientific SE has a market cap or net worth of EUR 9.08 billion. The enterprise value is 12.00 billion.

Market Cap	9.08B
Enterprise Value	12.00B

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	Jul 3, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.86%
Shares Change (QoQ)	-1.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	126.19M

Valuation Ratios

The trailing PE ratio is 27.86.

PE Ratio	27.86
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.22, with an EV/FCF ratio of 16.05.

EV / Earnings	36.82
EV / Sales	1.78
EV / EBITDA	8.22
EV / EBIT	14.62
EV / FCF	16.05

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.67.

Current Ratio	1.42
Quick Ratio	1.20
Debt / Equity	0.67
Debt / EBITDA	2.43
Debt / FCF	4.74
Interest Coverage	5.80

Financial Efficiency

Return on equity (ROE) is 7.27% and return on invested capital (ROIC) is 5.97%.

Return on Equity (ROE)	7.27%
Return on Assets (ROA)	4.85%
Return on Capital (ROIC)	5.97%
Revenue Per Employee	108,803
Profits Per Employee	5,274
Employee Count	61,798
Asset Turnover	0.64
Inventory Turnover	35.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.24%
50-Day Moving Average	47.74
200-Day Moving Average	52.78
Relative Strength Index (RSI)	51.15
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Eurofins Scientific SE had revenue of EUR 6.72 billion and earned 325.90 million in profits. Earnings per share was 1.67.

Revenue	6.72B
Gross Profit	1.49B
Operating Income	820.00M
Pretax Income	504.60M
Net Income	325.90M
EBITDA	1.31B
EBIT	820.00M
Earnings Per Share (EPS)	1.67

Full Income Statement

Balance Sheet

The company has 681.20 million in cash and 3.54 billion in debt, giving a net cash position of -2.86 billion.

Cash & Cash Equivalents	681.20M
Total Debt	3.54B
Net Cash	-2.86B
Net Cash Per Share	n/a
Equity (Book Value)	5.30B
Book Value Per Share	22.17
Working Capital	771.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.22 billion and capital expenditures -467.60 million, giving a free cash flow of 747.50 million.

Operating Cash Flow	1.22B
Capital Expenditures	-467.60M
Free Cash Flow	747.50M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 22.19%, with operating and profit margins of 12.20% and 5.64%.

Gross Margin	22.19%
Operating Margin	12.20%
Pretax Margin	7.50%
Profit Margin	5.64%
EBITDA Margin	19.45%
EBIT Margin	12.20%
FCF Margin	11.12%

Dividends & Yields

Eurofins Scientific SE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-50.00%
Years of Dividend Growth	n/a
Payout Ratio	59.30%
Buyback Yield	0.86%
Shareholder Yield	0.86%
Earnings Yield	3.51%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on November 19, 2020. It was a forward split with a ratio of 10.

Last Split Date	Nov 19, 2020
Split Type	Forward
Split Ratio	10

Scores

Eurofins Scientific SE has an Altman Z-Score of 2.45. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.45
Piotroski F-Score	n/a